ArticleJournal of maxillofacial and oral surgery2025
Mandibular Defect Reconstruction Using Tissue Engineering: Case Report and Long-Term Follow-Up.
Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on "Safety and Efficacy of Micronized Acellular Dermal Matrix Injection for Correction of Moderate to Severe Nasolabial Folds: A Double-Blind, Multicenter, Randomized Controlled, Non-inferior Clinical Trial".Aesthetic plastic surgery · 2026Article
- The Influence of the Topical Combined Application of Dexamethasone, Ascorbic Acid, and β-Sodium Glycerophosphate on Implant Osseointegration: A Split-Mouth Randomized Clinical Trial.International journal of dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue engineering is a new alternative for the treatment of severe mandibular defects, due to its low morbidity and predictability. Specifically, the use of adipose-derived stem cells (ADSc) combined with ceramic substitute like β-TCP. A male patient comes private clinic of Rodrigo Fariña, due to slow-growing and asymptomatic right facial asymmetry. The CT shows a unilocular radiolucent area of 6 cm in its longest axis with defined borders causing rizalysis of adjacent teeth in the right mandibular body. Histopathological examination after incisional biopsy, it´s diagnoses was plexiform unicystic ameloblastoma. Prior to surgical intervention, abdominal adipose tissue was collected for culture with osteoinductive media, in this case ascorbic acid and dexamethasone co-cultivated with blocks of β-TCP. One months later, the mandibular segmental resection with a safety edge is performed where, in the same surgical act, the combination of ADSc and the β-TCP is placed on a titanium mesh at the resection site. Six months later, a biopsy is performed that corroborates the bone neoformation where it is decided to carry out dental rehabilitation on osseointegrated implants. The combination of biomaterials in conjunction with ADSc allows an effective therapy, with a good prognosis for the treatment of severe mandibular defects caused by benign neoplasms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.